000 01104 a2200289 4500
005 20250517191518.0
264 0 _c20190930
008 201909s 0 0 eng d
022 _a1873-4286
024 7 _a10.2174/1381612824666171213102836
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOztekin, Cetin Volkan
245 0 0 _aMale Urogenital Disorders and Metabolic Syndrome: Possible Links, Characteristics and Potential Treatment Strategies.
_h[electronic resource]
260 _bCurrent pharmaceutical design
_c2018
300 _a1019-1033 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMale Urogenital Diseases
_xdrug therapy
650 0 4 _aMetabolic Syndrome
_xdrug therapy
700 1 _aKaya-Sezginer, Ecem
700 1 _aYilmaz-Oral, Didem
700 1 _aGur, Serap
773 0 _tCurrent pharmaceutical design
_gvol. 24
_gno. 9
_gp. 1019-1033
856 4 0 _uhttps://doi.org/10.2174/1381612824666171213102836
_zAvailable from publisher's website
999 _c27885820
_d27885820